News
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.… ...
June 18 (UPI) -- The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.
Any future candidate will be measured against the potency of the twice-yearly shot, which prevented nearly 100% of new HIV infections in two phase 3 randomized, controlled trials.
18d
Health and Me on MSNWHO Recommends New HIV Twice-Yearly Shot Amid Fund Cuts; What Are The Big Challenges The Drug Faces?WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV strategy with potential to curb new infections and improve access worldwide.
HIV protection with just two shots a year: FDA approves Gilead drug Lenacapavir, to be sold as Yeztugo, has potential to bring AIDS pandemic to heel but faces Trump-era obstacles ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results